Dr. Soileau discusses the clinical role of continuous subcutaneous Vyalev (foscarbidopa/foslevodopa) therapy for patients with Parkinson’s disease experiencing motor fluctuations despite optimized oral treatment. He reviews clinical trial data demonstrating
Joe Pierre, MD, summarizes his case report, “You’re Not Crazy”: A Case of New-onset AI-associated Psychosis,” examining the emerging phenomenon of artificial intelligence (AI)-associated psychosis. Using a real-world case of
Innov Clin Neurosci. 2026;23(4–6):5–9. Dear Editor: Dating apps and other social networks (DSN) that allow individuals to look for love and romance have fundamentally changed the big picture of the
Innov Clin Neurosci. 2026;23(4–6):5–9. Dear Editor: Clonidine is a central acting alpha-2 receptor agonist used for the treatment of psychiatric disorders and sleep difficulties. We report a pediatric patient who
Innov Clin Neurosci. 2026;23(4–6):5–9. Dear Editor: We read with great interest the study by Di Cesare et al,1 which introduces the Cognitive Assessment Tool for Pediatric Clinical Research (CAT-PCR), a
Dear Editor: We would like to thank the readers for their thoughtful and constructive comments on our study.1 We believe these observations are highly valuable in guiding test developers in
